GENE.V - Invictus MD Strategies Corp.

TSXV - TSXV Delayed Price. Currency in CAD
0.3600
+0.0100 (+2.86%)
At close: 3:56PM EDT
Stock chart is not supported by your current browser
Previous Close0.3500
Open0.3500
Bid0.3500 x 0
Ask0.3600 x 0
Day's Range0.3500 - 0.3600
52 Week Range0.3100 - 2.3400
Volume55,875
Avg. Volume166,430
Market Cap44.85M
Beta (3Y Monthly)3.78
PE Ratio (TTM)N/A
EPS (TTM)-0.3430
Earnings DateJun 28, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2016-11-17
1y Target Est2.25
  • Invictus MD Strategies Corp. Opens the Market
    CNW Group

    Invictus MD Strategies Corp. Opens the Market

    Invictus MD Strategies Corp. Opens the Market

  • GlobeNewswire

    ACREAGE PHARMS LTD. GRANTED OIL SALES LICENSE

    Vancouver, B.C., Aug. 14, 2019 -- Vancouver, BC, August 14, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor.

  • GlobeNewswire

    GENE SIMMONS ABDICATES ROLE AS CHIEF EVANGELIST OFFICER FOR INVICTUS

    Vancouver, B.C., Aug. 12, 2019 -- INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that rock icon and marketing.

  • GlobeNewswire

    ACREAGE PHARMS LTD. ACHIEVES SUBSTANTIAL COMPLETION OF 90,000 SQUARE FOOT PHASE III FACILITY

    Vancouver, Aug. 06, 2019 -- Vancouver, BC, August 6, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor.

  • GlobeNewswire

    Invictus announces Annual General Meeting Results

    Vancouver, British Columbia, July 25, 2019 -- Vancouver, BC, July 25, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA:.

  • GlobeNewswire

    Invictus announces Closing of Non-Brokered Private Placement

    Vancouver, British Columbia, July 09, 2019 -- Vancouver, BC, July 9, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2).

  • GlobeNewswire

    Invictus announces Non-Brokered Private Placement

    Vancouver, British Columbia, July 03, 2019 -- Vancouver, BC, July 3, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2).

  • GlobeNewswire

    INVICTUS ANNOUNCES AB VENTURES INC. UPDATE

    FRA: 8IS2) Mr. Trevor Dixon, Chief Executive Officer of Invictus, is pleased to report that AB Ventures Inc. (“AB Ventures”), a company which Invictus is a 25% shareholder, is a late stage applicant to obtain a cultivation license under the Cannabis Act. AB Ventures received the approval to proceed to construction and will submit its evidence package upon completion of such construction.

  • GlobeNewswire

    INVICTUS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS

    FRA: 8IS2) today reported financial results for the first quarter ended April 30, 2019. “We are pleased with the progress on reducing the cost of Invictus’ operations and the increases to date on the income generation capacity of the Company. Continued focus on increasing capacity and cost reduction is paramount in developing a profitable business,” stated Mr. Trevor Dixon, Chief Executive Officer of Invictus.

  • GlobeNewswire

    INVICTUS ANNOUNCES AB LABORATORIES INC. UPDATE

    Vancouver, June 26, 2019 -- Vancouver, BC, June 26, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon,.

  • GlobeNewswire

    Invictus announces Annual General Meeting Date

    Vancouver, British Columbia, June 20, 2019 -- Vancouver, BC, June 20, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2).

  • GlobeNewswire

    UPDATE ON ACREAGE PHARMS LTD.

    Vancouver, British Columbia, June 12, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive.

  • GlobeNewswire

    INVICTUS ANNOUNCES APPOINTMENT TO BOARD

    FRA: 8IS2) announced today that Mr. Colin Kinsley has been appointed to the Board of Directors as an independent Director.  Mr. Kinsley previously served on the Board of Directors of the Corporation (the “Board”) from December, 2014 to June, 2017. Mr. Trevor Dixon, the Company’s Chief Executive Officer, said, “The Company is very pleased to have Mr. Kinsley join the Board.

  • A Look At The Intrinsic Value Of Invictus MD Strategies Corp. (CVE:GENE)
    Simply Wall St.

    A Look At The Intrinsic Value Of Invictus MD Strategies Corp. (CVE:GENE)

    Today we will run through one way of estimating the intrinsic value of Invictus MD Strategies Corp. (CVE:GENE) by...

  • GlobeNewswire

    INVICTUS ANNOUNCES EXECUTIVE APPOINTMENT

    Vancouver, June 05, 2019 -- Vancouver, BC, June 5, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today.

  • GlobeNewswire

    INVICTUS ANNOUNCES CHANGES TO BOARD

    FRA: 8IS2) announced today that Mr. Richard Lee has been appointed to the Board of Directors as an independent Director.  Mr. Aaron Bowden has submitted his resignation as a Director in order to devote more time to his other business interests.  Mr. Bowden will continue to serve the Company as an advisor.  Mr. Bowden was appointed to the Board of Directors on August 19, 2016 and served as Chair of the Audit Committee.

  • GlobeNewswire

    INVICTUS ANNOUNCES CHANGE TO MANAGEMENT AND BOARD

    FRA: 8IS2) announces that the Board of Directors (the “Board”) has accepted Mr. George E. Kveton’s resignation as Chief Executive Officer (“CEO”) of the Company and Mr. Trevor Dixon, a member of the Board, will be assuming the role of CEO. “I am proud to be serving as the Company’s CEO,” said Mr. Dixon.  “I am committed to the long term and ongoing success of the Company as we work to improve production, increase revenue and decrease the cost of operations.

  • GlobeNewswire

    Invictus Withdraws Plans for NASDAQ Listing and Related Share Consolidation

    FRA: 8IS2) announced today that the Company is withdrawing plans to list the Company’s common shares (the “Shares”) on NASDAQ Stock Market LLC (“NASDAQ”), as well as plans for the share consolidation that would have been required to meet NASDAQ’s minimum share price listing threshold. Plans for the NASDAQ listing and a share consolidation were originally announced in press releases dated January 17, 2019 and January 21, 2019.

  • CNW Group

    Invictus Announces Appointment of Director and Chief Operating Officer

    FRA: 8IS2) the Company is pleased to announce the appointment of Trevor Dixon as a Director and Chief Operating Officer of the Company effective immediately.  Mr. Dixon is the founder, President and Chief Executive Officer of the Company's wholly owned subsidiary Acreage Pharms Ltd. ("Acreage Pharms"). "Mr. Dixon brings 35 years of successful business experience to the leadership team of Invictus," said George E. Kveton, CEO of Invictus.

  • GlobeNewswire

    INVICTUS GRANTS OPTIONS

    Vancouver, BC, April 26, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) the Company has granted 200,000 incentive.

  • GlobeNewswire

    Invictus To Develop CBD-Infused Sodas with Rock Icon Gene Simmons and Simmons’ Moneybag™ Sodas

    FRA: 8IS2) announced today that it has entered into a letter of intent (“LOI”) to form a Joint Venture (“JV”) with Gene Simmons (“Simmons”), Simmons’ MoneyBag Sodas (“MoneyBag™”) and  Rock Steady Sodas, Inc. (“Rock”) (each a “Party” and collectively the “Parties”) to develop a line of non-alcoholic, CBD-infused beverages for distribution in the United States and Canada. Rock will contribute expertise with existing premium soda recipes to be used with CBD and generations of bottling and distribution experience.

  • Did You Miss Invictus MD Strategies's (CVE:GENE) Impressive 116% Share Price Gain?
    Simply Wall St.

    Did You Miss Invictus MD Strategies's (CVE:GENE) Impressive 116% Share Price Gain?

    It hasn't been the best quarter for Invictus MD Strategies Corp. (CVE:GENE) shareholders, since the share price has fallen 25% in that time. But in three years the returns have been great. In fact, the share price is...

  • GlobeNewswire

    INVICTUS MAKES FIRST SHIPMENT TO ONTARIO CANNABIS STORE

    Vancouver, BC, April 01, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased to have made its inaugural shipment.

  • GlobeNewswire

    GENE SIMMONS TAKES INVICTUS ON TOUR

    Vancouver, BC, March 25, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to report that the Company’s Chief.